07 Jun BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration
OTTAWA, Ontario--(BUSINESS WIRE)--$BWXT--BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient. Ac-225 is an alpha-em...